Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-11

Clinical Trial Update: Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing Chikungunya During a Pilot Vaccination Strategy in Brazil

View source ↗

Summary

An observational study is being conducted to assess the effectiveness of the VLA-1553 chikungunya vaccine in preventing chikungunya during a pilot vaccination s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VLA-1553 vaccine (VLA-1553)

Snippet

Sponsor: Valneva Austria GmbH | Conditions: Chikungunya Virus Infection | Status: ENROLLING_BY_INVITATION